Loading...
Glutamate and dopamine components in schizophrenia
The treatment of schizophrenia for the last half century has been with dopamine (DA) D(2) receptor blockers, implicating a hyperdopamine basis for psychosis. However, a 2007 report found that the glutamate agonist LY404039 was effective in schizophrenia, suggesting a hypoglutamate state for the illn...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Canadian Medical Association
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2647567/ https://ncbi.nlm.nih.gov/pubmed/19270765 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|